PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.260
+0.045 (3.70%)
At close: Aug 14, 2026, 4:00 PM EDT
1.270
+0.010 (0.79%)
After-hours: Aug 14, 2026, 4:10 PM EDT
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $67.2 million as of August 14, 2026. Its market cap has decreased by -16.58% in one year.
Market Cap
67.20M
Enterprise Value
-12.02M
1-Year Change
-16.58%
Ranking
Category
Stock Price
$1.26
ChartMarket Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $67.20M, a decrease of -95.83%. That is a compound annual growth rate of -41.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 67.20M | 1.03% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 69.55M |
| Rein Therapeutics | 67.36M |
| Cardiff Oncology | 67.28M |
| Cingulate | 67.21M |
| Pliant Therapeutics | 66.87M |
| ImageneBio | 66.63M |
| Dogwood Therapeutics | 66.59M |
| MindWalk Holdings | 65.31M |